Bachelor of Medicine from the Universidad de Zaragoza PhD from the Universitat Rovira i Virgili Founder of the Infection and Immunity (INIM) Research Group.
Since 1984, when the first HIV patients were diagnostic at the Hospital Universitari de Tarragona Joan XXIII, I have been interested in the genetic factors involved in the vulnerability to HIV infection and disease progression. In 1995, Professor Francesc Vidal proposed to set up a research group to study of the immunogenetics and immunopathogenesis of HIV. Thenceforth, I have been working to stablish national and international HIV cohorts and actively participate in the Spanish AIDS Network (RETICS-RIS; ISCIII).
Nowadays, I have focused my research in the evaluation of the efficacy and safety of antiretroviral drugs, which made me, participated in different projects to study mechanisms of toxicity with particular emphasis in inflammation, lipodystrophy and other metabolic side effects. Moreover, I also focuse my interest to study the patients known as “HIV elite controllers” and “long-term nonprogressors”, a small quantity of people with HIV that can handle the infection without any apparent problems, with no symptoms of HIV infection and no signs of disease progression.
In addition to my research concerns, at present I am adjunct lecturer at Universitat Rovira i Virgili where I teach Clinical II, Medical Clinical and Infectious Diseases for the Bachelor of Medicine.